Cardiovascular Pharmacotherapy Focus

QR Code

Cardiovascular Pharmacotherapy Focus

Enregistré dans:

Détails bibliographiques
Auteur principal:	Pablo Avanzas
Format:	article
Langue:	EN
Publié:	Radcliffe Medical Media 2019
Sujets:	Diseases of the circulatory (Cardiovascular) system RC666-701
Accès en ligne:	https://doaj.org/article/d10ff26d0f3b4a458e2ed6b2720c8e4c
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Cardiovascular Imaging and Theranostics in Cardiovascular Pharmacotherapy
par: Mattia Cattaneo, et autres
Publié: (2019)

24th Annual Scientific Meeting of the International Society of Cardiovascular Pharmacotherapy
par: Hector Ventura
Publié: (2020)

Posters from the 24th Annual Scientific Meeting of the International Society of Cardiovascular Pharmacotherapy
par: BMY Cheung, et autres
Publié: (2020)

Pharmacotherapy in Stable Coronary Artery Disease: Historical Perspectives and New Insights from the ISCHEMIA Trial
par: Jonathan Yap, et autres
Publié: (2021)

Editorial: The EXCEL Trial
par: Pablo Avanzas, et autres
Publié: (2021)

The ISCHEMIA Trial: And the Winner Is… the Patient
par: Pablo Avanzas, et autres
Publié: (2021)

The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
par: Eliecer Coto, et autres
Publié: (2021)

The Role of C-reactive Protein in Patient Risk Stratification and Treatment
par: Ramón Arroyo-Espliguero, et autres
Publié: (2021)

Inflammation and Cardiovascular Disease: The Future
par: Natalie Arnold, et autres
Publié: (2021)

The Effect of Testosterone on Cardiovascular Disease and Cardiovascular Risk Factors in Men: A Review of Clinical and Preclinical Data
par: Hargun Kaur, et autres
Publié: (2021)

Meditation and Cardiovascular Health: What is the Link?
par: Sebastian Schnaubelt, et autres
Publié: (2019)

Deciphering the Riddles in Nutrition and Cardiovascular Disease
par: Amelia Carro, et autres
Publié: (2019)

COVID-19 Pandemic and Cardiovascular Disease
par: Aniket S Rali, et autres
Publié: (2020)

The Association Between Psoriasis and Cardiovascular Diseases
par: Ahmed Zwain, et autres
Publié: (2021)

Effects of aerospace environments on the cardiovascular system
par: Erdinç Ercan
Publié: (2021)

Focusing on Referral Rather than Selection for Advanced Heart Failure Therapies
par: Tonje Thorvaldsen, et autres
Publié: (2019)

Porcelain aorta rupture after cardiopulmonary resuscitation
par: Iria Silva, et autres
Publié: (2021)

Porcelain aorta rupture after cardiopulmonary resuscitation
par: Iria Silva, et autres
Publié: (2021)

Novel Cardiovascular Biomarkers Associated with Increased Cardiovascular Risk in Women With Prior Preeclampsia/HELLP Syndrome: A Narrative Review
par: Esmee ME Bovee, et autres
Publié: (2021)

New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
par: Alberto J Lorenzatti, et autres
Publié: (2020)

Viscoelastic Haemostatic Assays in Cardiovascular Critical Care
par: Aniket S Rali, et autres
Publié: (2021)

Left Main Disease and Bifurcation Percutaneous Coronary Intervention: Focus on Antithrombotic Therapy
par: Charalampos Varlamos, et autres
Publié: (2021)

Electronic Cigarettes and Cardiovascular Risk: Caution Waiting for Evidence
par: Domenico D’Amario, et autres
Publié: (2019)

Secondary Prevention of Cardiovascular Disease in Women: Closing the Gap
par: Aarti Thakkar, et autres
Publié: (2021)

Cardiovascular Outcomes in Trials of New Antidiabetic Drug Classes
par: Chris Wai Hang Lo, et autres
Publié: (2021)

Coronavirus Disease 2019: Psychological Stress and Cardiovascular Diseases
par: Maki Komiyama, et autres
Publié: (2021)

The Fourth Trimester: Pregnancy as a Predictor of Cardiovascular Disease
par: Pensée Wu, et autres
Publié: (2021)

New opportunities for reducing cardiovascular risk in the Russian Federation
par: O. D. Ostroumova, et autres
Publié: (2020)

Obesity and Cardiovascular Risk After Quitting Smoking: The Latest Evidence
par: Koji Hasegawa, et autres
Publié: (2019)

Electronic Cigarettes and Cardiovascular Risk: Science, Policy and the Cost of Certainty
par: Olusola A Orimoloye, et autres
Publié: (2019)

Non-invasive Low-level Tragus Stimulation in Cardiovascular Diseases
par: Yunqiu Jiang, et autres
Publié: (2020)

Anti-inflammatory Treatment and Cardiovascular Outcomes: Results of Clinical Trials
par: Alberto J Lorenzatti
Publié: (2021)

Cardiovascular and Renal Risk Factors and Complications Associated With COVID-19
par: Rhian M. Touyz, MBBCh, PhD, et autres
Publié: (2021)

Trending cardiac biomarkers during pregnancy in women with cardiovascular disease
par: Soohyun Chang, et autres
Publié: (2021)

COVID-19: a patient with cardiovascular disease at high risk
par: Irina E. Chazova, et autres
Publié: (2020)

Behavioural Interventions to Reduce Cardiovascular Risk: Where Do We Stand?
par: Gianluigi Savarese
Publié: (2019)

Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic Treatment
par: Anne Mirjam Kerola, et autres
Publié: (2021)

Assessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the Science
par: Charles Amir German, et autres
Publié: (2020)

Cardiovascular Clinical Trials in a Pandemic: Immediate Implications of Coronavirus Disease 2019
par: Ernest Spitzer, et autres
Publié: (2020)

Cardiovascular Benefits of New Antidiabetic Drug Classes: A Network Meta-analysis
par: BMY Cheung, et autres
Publié: (2020)